Ординатура / Офтальмология / Английские материалы / Artificial Sight Basic Research, Biomedical Engineering, and Clinical Advances_Humayun, Weiland, Chader_2007
.pdf380 Hetling
11.Bearse MA Jr. & Sutter EE (1996). Imaging localized retinal dysfunction with the multifocal electroretinogram. Journal of the Optical Society of America, A, Optics, Image Science, & Vision. 13(3):634–40.
12.Enroth-Cugell C & Robson JG (1966). The contrast sensitivity of retinal ganglion cells of the cat. Journal of Physiology 187:517–552.
13.Passaglia CL, Troy JB, Ruttiger L & Lee BB (2002). Orientation sensitivity of ganglion cells in primate retina. Vision Research. 42(6):683–94.
14.Baig-Silva MS, Hathcock CD & Hetling JR (2005). A preparation for studying electrical stimulation of the retina in vivo in rat. Journal of Neural Engineering 2:S29–S38.
15.Yang, X-L (2004). Characterization of receptors for glutamate and GABA in retinal neurons. Progress in Neurobiology 73:127–150.
16.Robson JG & Frishman LJ (1999). Dissecting the dark-adapted electroretinogram.
Documentia Ophthalmologica 95:187–215.
17.Xu L, Ball SL, Alexander KR & Peachey NS (2003). Pharmacological analysis of the rat cone electroretinogram. Visual Neuroscience 20:297–306.
18.Hetling JR & Baig-Silva MS (2004). Neural prostheses for vision: Designing a functional interface with retinal neurons. Neurological Research, 26:21–34.
19.Hafezi F, Grimm C, Simmen BC, et al. (2000). Molecular ophthalmology: an update on animal models for retinal degeneration and dystrophies. Br J Ophthalmol. 84:922–927.
20.Jones BW & Marc RE (2005). Retinal remodeling during retinal degeneration.
Experimental Eye Research 81:123–137.
21.Machida S, Kondo M, Jamison JA, et al. (2000). P23H rhodopsin transgenic rat: correlation of retinal function with histopathology. Invest Ophthalmol Vis Sci. 41:3200–3209.
22.Marc RE, Jones BW, Watt CB, Strettoi E (2003). Neural remodeling in retinal degeneration. Prog Retin Eye Res 22:607–655.
23.Meyer RD, Cogan SF, Nguyen TH, Rauh RD (2001). Electrodeposited iridium oxide for neural stimulation and recording electrodes. IEEE Trans Neural Syst Rehabil Eng 9:2–11.
24.Slaughter MM & Miller RF (1981). 2-amino-4-phosphonobutyric acid: A new pharmacological tool for retina research. Science 211:182–185.
25.Brandstätter JH, Koulen P, Kuhn R, van der Putten H & Wässle H (1996). Compartmental localization of a metabotropic glutamate receptor (mGluR7): two different active sites at a retinal synapse. Journal of Neuroscience 16:4749–4756.
26.Murakami M, Otsuka T & Shimazaki H (1975). Effects of aspartate and glutamate on the bipolar cells in the carp retina. Vision Research 15:456–458.
27.Slaughter MM & Miller RF (1983). An excitatory amino acid antagonist blocks cone input to sign-conserving second-order retinal neurons. Science 219:1230–1232.
28.Davies J (1982). Conformational aspects of the actions of some piperidine dicarboxylic acids at excitatory amino acid receptors in the mammalian and amphibian spinal cord. Neurochemical Research 7(9):1119–33.
29.Hashimoto K & Kan M (1998). Presynaptic origin of paired-pulse depression at climbing fibre Purkinje cell synapses in the rat cerebellum. Journal of Physiology 506.2:391–405.
30.Massey SC & Miller RF (1990). N-methyl-D-aspartate receptors of ganglion cells in rabbit retina. Journal of Neurophysiology 63:16–30.
Index
2-amino-4-phosphonobutyrate, 376
2D models, 298
2D retinal image, projection of into a 3D world, 59
Acrylic, 1, 5
Activities of daily living and orientation, testing of, 105–108
Admittance method, 295 Adverse effects, 125
Age-related macular degeneration, 14–15, 32, 129, 170, 209, 223, 255, 280, 334, 347
disciform, 15, 17 dry, 14, 15 incidence of, 14 neovascular, 14 treatments for, 15 wet, 14
research on, 15 Agonists, 365, 374–378
definition of, 374–375 Algorithms, 115, 132, 198 image-processing, 132
Aluminum, 152, 159 Amacrine cells, 114 , 353, 365 Amblyopsis, 102–103
Ames’ medium, 214–215 Ampere’s Law, 281 Anatomy of the eye, 2–9 Anecortave acetate, 15 Animal experiments, 189–197
Animal models, 33–39, 93, 367 Animals, experimental
cats, 37, 38–39, 212, 213, 316, 317, 318, 319 chickens, 267–270
dogs, 10, 20, 60 frogs, 161, 167
guinea pigs, 219, 334, 335, 338, 339, 342 macaques, 48–49, 335
mice, 364 mini pigs, 119
monkeys, 48–49, 55, 57, 309, 310, 311, 319, 333–335, 338, 339
pigs, 367
rabbits, 36–38, 189, 190, 197, 267–270, 325–331, 348, 367
rats, 34, 39, 267–270, 334, 338–339, 342, 361, 367, 370
Anodic reactions, 232–234 Anterior chamber, 4, 5, 9 Antiangiogenic drugs, 15 Aqueous humor, 4
Artifact subtraction, 337–340, 343 Artificial sight, 219, 343 Artificial vision devices, 91
resolution and acuity of, 98 Aspartate, 365, 375, 376, 378
Attachment of an array to the retina, 20–23 Auditory cortex
changes in/changes of blind subjects, 53 cross-modal connections to, 56 cross-modal responses in, 56 deterioration of in deaf individuals, 61–62 recruitment of, 56
Auditory deprivation, 48, 54, 561
Auditory development, critical period for, 61 Average evoked response, 321
Axons, 316
optic nerve, 355
retinal ganglion cell, 34
BaGA test, 99, 102–103, 104–105 technical setup for, 98–100
BaLM test, 97, 98, 99, 100, 103, 105 technical setup for, 97, 98
Basic fibroblast growth factor, 40, 42 Basic grating acuity test, 99, 103
technical setup for, 103
Basic light and motion test, 97, 98 technical setup for, 97
Batteries, 116, 121, 172
Behavioral symptoms, measurement of, 108 Bidirectional communication, 172, 175 Binarization circuit, 158
Binary morphological operations, 158
381
382 Index
Bioadhesives, 21
Biocompatibility, 119, 159, 206, 211, 218, 223, 229, 244, 280, 369
Bioelectrical signals, conduction of, 194, 196 Bio-heat equation, 284, 285
formulation of, 284–287 Biological environment, protection
against, 159
Biological tissue, electrical stimulation of, 252
Biphasic current controllers, 172, 182–184 Biphasic current pulses, 161, 167, 202, 203,
230, 247
Biphasic current waveforms, 170, 182 Biphasic output, 154
Biphasic pulses, 38, 216, 217, 218, 219, 220, 223, 233, 235, 308, 349
charge-balanced, 235, 309 current, 161, 167, 202, 203, 247,
251–252, 333
minimization of pH changes by, 235 square-wave, 370–371
Biphasic stimulation, 140
Biphasic voltage generator, pulsed, 274 Biphasic waveforms, 171, 181, 184 Bipolar cells, 6, 257, 280, 365, 374, 376
retinal, 259
Blindness, early and late, 51 Blood circulation, 289
Blood perfusion, 285, 287, 289 Blurring, 157, 158
Braille reading, 54–55, 64 Brain
direct stimulation of, 353, 372 plasticity of, 47
posterior (occipital) pole of, 308 Brain-derived neurotrophic factor, 40, 42 Brief symptom inventory (BSI), 108 Brightness
perception of, 124–125 testing of, 100
Broadcast architectures, 166 Brodmann’s areas, 56, 57 Buffering, 232
Buffers, data, 176
Cameras, 258, 280
charge coupled device, 73 CMOS, 197
implantable, 188 digital, 111, 112, 129, 132 micro
evaluation of, 204–205 implantable, 203–206
video, 270–271 Capacitance, 153 Capacitive charge flow, 252
Capacitors, storage, 142–143 Carbon black, 264 Cataracts, 5, 50
removal of, learning deficit after, 50 Cataract surgery, 1, 5, 22
diagram of, 5
Cathodic reactions, 232–233 CCD array, 273
Cell membrane, depolarization of, 261 Cells
polarization of, 259 recruitment of, 372
Cell stimulation, voltage and current required for, 259–261
Cellular translocation, 17
Central nervous system, 212, 219, 319, 358 Cerebral cortex
cat, 313, 317 microstimulation of, 307–321
Charge, 38
Charge capacity, electrode material, 117 Charge coupled device, 73, 197
Charge coupled device array, 273
Charge densities, 37–38, 194, 221, 244, 264, 331, 338, 353
electrode–electrolyte interface, 211 levels of, 121
low, 342
reducing the size of stimulating electrodes on, effects of, 353
stimulus, 312–314 very high, 342
Charge density burden, 212
Charge density thresholds, 18–19, 37–38, 215–216, 264, 333–334
Charge injection capability, 251–253 Charge injection, neuralprosthesis, 229 Charge per phase, stimulus, 312–314 Charge stimulation thresholds, 334 Charge storage, 213
Charge transfer resistance, 262 Checkerboards, 100
patterns of, 363 Checkerboard test, 74–76 Checker placing, 79–81
practice effect in, 81
Choroid, 5, 6, 24, 33, 190, 289, 325–331, 369 Choroidal detachment, 19
Choroidal vessels, enlargement of, 329 Ciliary neurotrophic factor, 40, 42 Cis-2,3-piperidinedicarboxylate, 376
Clinical studies, 119–126 Clock cycle, 184 CMOS, 188
Cochlear implants, 48, 61, 62, 64, 222, 229, 256, 258, 319
success of, 61
Cochlear nucleus, 310, 311, 316, 319–321 implantation in, 319–321
Cognitive system, 91 Coil geometries, 280 Coils, 138–140, 172
coupling and loading of, 143 external and internal, 280 implanted, modeling of, 291–292 models of, 282–286
quality factors of, 139 Colliculus, 320
superior, 34 Color
discrimination of, 59 perception of, 124–126 stimulation of, 194
Color vision, 92
Compensation for a missing sense, 50–52 Compensation, neural basis of, 52–57 Compensatory hypertrophy, 56 Complementary metal oxide semiconductor
(CMOS), 151
Complications during surgery, 20, 25, 125 Computational challenges, 300–301 Computational modeling, 279–303 Computer-aided learning, 111
Cones, 6
Conjunctiva, 4, 5, 12, 13
Contrast sensitivity, testing of, 101, 103–104 Convection coefficients, 289
Conversion
digital to analog, 179–182 serial to parallel, 178–179
Cornea, 5, 8 Cortex, 91, 194
auditory, 52, 53, 56, 61–62 cerebral, 308–321 inferotemporal, 49 parietal, 54 somatosensory, 52, 53
visual, 48, 52, 53, 54, 95, 187, 319, 321, 347 Cortical areas, differences between, 47–50 Cortical auditory evoked potential after
cochlear implant, 61 Cortical mapping, 48
Cortical reorganization, 47, 54 Cortical resources, competition for, 64 Counting tasks, 75, 76, 77, 79, 81
Index 383
Coupling of coils, computation of, 282–286 Cross-modal influences, anatomical
substrates of, 55
Cross-modal plasticity, 51, 52, 54–57, 61, 64 in deaf individuals, 55–57
Cross-modal plasticity in restoration of a sense, 57
Cross-modal processing, interference with a, 55, 63
Cross-modal responses critical period of, 55
in sighted individuals, 55 tactile, 56
within right auditory cortex, 56 Cross-modal responsivity, 54 Crosstalk, 334, 343
Current densities, 265, 299
Current densities in the retina, 294–301, 302–303
Current injection, 293, 294
Current loops, decomposition of, 281 Current pulse stimulation (PS), 246 Current sources, 161, 295, 299 Current spread, 279, 301, 338 Current spread simulations, 301–302 Current stimulation thresholds, 334 Cyclic voltammetry, 246, 251
Data buses, 176 Data communication
bidirectional, 175, 185 wireless, 143–146
Data conversion, 179–181 Data rates, 144, 174
Data telemetry, 279 forward, 144–146 reverse, 146
Deafness, compensation for, 56 Decimal acuity, 92 Decimation algorithms, 198 Decoders, 176
Degradation, 2 Demultiplexing, 136–137 Densities, charge current, 334 Detachment
choroidal, 19
retinal, 1, 6, 12–13, 23, 24, 25, 125, 369 diagram of, 8
Diabetes mellitus, 13
Diabetic retinopathy, 13, 71, 120 Diagnostics, 10
Digital-to-analog current converters, 172, 179–181
Dining table scenery, 106–107
384 Index
Dipole electric potential, 260 Dipole moment, neuron, 358 Directshow, 73
Direct wiring, 245
Disciform macular degeneration, 15 Disease
retinal, 13–19 degenerative, 12, 13 vascular, 13
Double layer capacitance, 250 Duty cycle, 259
Edema, 119
Edge detection, 157, 199–200
Edge detection algorithms, 198, 201
Edge enhancement, 152, 156, 157, 158, 198 Edge enhancement algorithms, 198, 201 Edge following, 200
Electrical activation, neuroprotection by, 40
Electrical activity, cellular effects of, 39 Electrical current, 33, 35, 39, 117, 139, 326,
330, 342 Electrical damage, 2
Electrical evoked cortical potentials, 190–191, 192
Electrically elicited electroretinograms interpretation of, 376
pharmacological dissection of, 374–378 Electrically evoked potentials, 34, 36–38, 38,
41, 163, 326, 330 Electrically evoked response, 18
Electrical potential, distribution of, 266 Electrical potential across an interface, 211 Electrical stimulation, 111, 349
biological tissue, 252
differences from responses to light of, 371 effect of on the retina, 31
ganglion cell layer, 347 high-frequency, 340–342 perception after, 123
pH changes induced by, 232–240 response of the retina to, 366–378 retinal, 1, 72, 111, 116, 118, 126,
129, 210, 255 intraocular, 121 safety of, 119
safety of, 330
tissue damage by, 227 upregulation by, 40
Electrical stimulation therapy, 43 Electric fields
divergence of, 265–266 non-uniform, 374
Electric pulse train, 122, 347, 355, 373 Electrocardiogram, 358
Electrochemical characterization, 243–253 Electrochemical impedance spectroscopy,
246, 248 Electrochemical reactions,
263–265
at the electrode-vitreous interface, 211–218 Electrode arrays, 32, 36, 119
modeling of, 292–294 small, 369–370
Electrode-electrolyte interface, ph changes at, 232, 235
Electrode implantation, 38 Electrode materials, 218–219
electrical properties of, 211 Electrodes
addressing of, 165
biological environment, 159–161 capacitance of, 250–251 capacitative, advantages of, 213 charge-injection, 244
contact spiral cuff, 188 corrosion of, 252 counter, 39
current pulsed, 211 disk, platinum, 334 dissolution of, 213 epiretinal, 37
gold, 219, 244–245, 369, 371 intracortical, 307–321 iridium, 219, 244, 311
iridium oxide, 262, 263, 264–265, 311, 369 low impedance, 141, 219, 222 MEMS-based, 229
microbump, 169
nanopowder molding of, 244, 245, 246, 253 neurostimulatory, 212–213
optic nerve penetrating, 187, 188, 189, 191, 193, 194, 195, 197, 198, 203, 206
placement of, 190, 192, 193
platinum, 212, 213, 215, 217, 219, 222, 230, 244–245, 262, 264–265, 273–274, 325
dissolution rates of, 220 electrochemical characterization of,
243–253
molded, 245, 248, 251, 252, 253 electrical impedances of, 250 electrical resistivities of, 248
platinum–iridium, 219, 349 protruding, 269–270 recording, 190
placement of, 195
retinal prosthesis, 209, 210, 211, 212, 213, 219, 220, 221, 222, 223, 227, 255–275
operational stability of, 219–221 small-diameter, 333–343
stacked bump, 159–161, 162 stimulating, 32, 33, 36–37, 94
effects of reducing the size of all on charge density of, 353
placement of, 190 platinum, 236
stimulus, large scale integration, 151–167 subretinal, 38, 375
surface area of, 253 surface roughness of, 253 titanium, 244
Electrode stimulation, 230
Electrode surface area, effective, 221–223 Electrode test apparatus, 214–218 Electrode-vitreous interface, 211–218 Electroencephalograms, 358
Electromagnetic effects, modeling of, 279–303 Electrophysiological examinations, 92 Electrophysiological experiments, 156, 158,
161–162, 167
Electrophysiological tests, limited value of, 98 Electrophysiology, 355–379
invasive techniques of, 364, 373–374 noninvasive techniques of, 360–364, 373
Electroplating, 245
Electroretinograms, 10–12, 15, 16, 43, 92, 93, 360–364, 370–373
corneal, 367
electrically elicited, 374–378 focal, 362, 370–372 light-induced, 371
limits of, 12 mid-flash, 372–373 multifocal, 362–364
Encoders, 176 Energy density, 137
Epiretinal approaches, 19–23 surgical limitations of, 19–20
Epiretinal implants, 343 Epithelium, retinal pigment, 369 Everyday tasks
mastery of, 106 performance of, 105–107
testing of, 96 Evoked potentials, 35
Evoked responses, collicular, 35 Extracellular recordings, 358, 359, 364 Extracellular stimulation, passive model of,
259–261
Index 385
Extraocular units for wireless prostheses, 169–170
Eye
anatomy of, 2–9 anterior segment of, 3–5 physiology of, 2–9 posterior segment of, 5 stimulation of, 18
Eyeball
anterior structure of, 4 cross section of, 3
Eye disease, animal models of, 367 Eye dominance, 89
Faradaic charge flow, 252 Faradaic charging, 212 Faradaic processes, 263–265 Faradaic reactions, 214, 264 Faraday’s Law, 281 Fibrosis, 20
Field of vision, normal, 9 Field potential, 372
Field potential recordings, 358, 359 Filtering, spatial, 156
Fine wire probes of the eye, 364 Finger counting, 39, 97
definition of, 32
Fingers, smearing of information across, 53 Firing rate, 161–162, 364, 373
Flexibility of stimulation, 144 Flickering, 18, 99, 133, 136, 308 Fluorescein angiogram, 9–10 Fluorescent dye, 41
Focal electroretinograms, 362, 370–372 Fourier’s Law, 287
Frame rate, 170
Freiburg Visual Acuity and Contrast Test (fract), 98, 103–104
Frequency limitation, 154–155 Frequency of stimulation, 337
Functional magnetic resonance imaging, 48, 50–51, 53, 54, 59, 60
Functional mapping, 359 Fundus, 9, 15
appearance of, 15 diagram of, 6
Fundus photo, 10
GABA, 365
Gain, electrical, 360
Ganglion cell layer, 17, 23–24, 34, 347, 368 retinal, 373
386 Index
Ganglion cells, 6, 16–17, 21, 111, 114, 188, 257, 258, 274, 275, 280, 301, 333–343, 365
measuring the activity of, 363 protection of, 40
spiking of, 364
early and late phases of, 352–353 Glaucoma, 5, 20, 120, 307
Glial tissue, 32 Gliosis, 20, 25
Glutamate - aminobutyric acid, 365 Glutamine synthetase, 42
Gold, 159–160, 161, 162, 219, 244–245, 369, 371
Gradiant filters, 200
Grating acuity, assessment of, 102–103, 104–105
Grating acuity test, 98 Gray level, 181
pixel, 170
Hand dominance, 89
Hand–eye coordination, 81–83, 85 Hearing, blind individuals’ abilities for, 51 Heat
diffusion of, 262 dissipation of, 204, 291–292 metabolic, 287
radiated, 172
Heating of tissues, 245, 261–263
Higher visual areas, neuronal responses in, 54 Histogram equalization, 199, 201
Hydrogels, 21
Hydrogen evolution, electrolytic, 216, 218 Hypertension, 13
Hypertrophy, 329 compensatory, 53–54
Hypotony, 19
IGF-1, 40, 41, 42
IIP retinal implant system, 111–126 Image acquisition, 197–198
Image processing, 91, 156–159, 273 adjustable, 258 location-dependent, 258, 274–275 retinal, 132
Image-processing algorithms, 188 Image-processing strategies, 198–202 Image projection, 269–273
Image quality, 115 Impedance method, 295–300
simulation of, 295–303 Impedance networks, voxel, 298–299
Implantation
cochlear nucleus, 319–321 electrode, 38
microelectrode array, 210, 227 microelectronic device, 21–23 microstimulating array, 311 retinal prosthesis, 162–167 subretinal, 23–25, 151, 257 suprachoroidal, 151
surgical procedures for, 36–37 Implantation in the eye, 19, 21–25 Implant design, limiting factors on, 2 Implants
cochlear, 40, 61, 62, 64, 222, 229, 256, 258, 319
common qualities of, 1 epiretinal, 111, 343 intraocular, 227
issues with, 2 microarray, 169–186 ocular, 1 optoelectronic, 273–274 retinal, 19–25, 111–126 subretinal, 171, 255
wireless-microarray, 169–186
Inductive coupling, 138–139, 279, 280–283 Inductive radiofrequency transmission, 274 Inferotemporal cortex, macaque, 49 Information encoded at the retinal level, 93 Information flow, 365
Information gathering, 355 Information processing, 114 Information transmission, 269–275 Infrared data transmitter, 114 Inner limiting membrane, 41
Inner nuclear layer, 6, 17, 23–24, 34 nuclear condensation of cells of, 329
Insulin-like growth factor–1, 40, 41, 42 Interface, electrode-vitreous, 211–218 Interference, 259
telemetry, 145 Interphase interval, 133
Intracellular recording, 358, 359
Intracortical microstimulation (ICMS), 307–321 Intraocular pressure, 2, 5, 12, 19, 20–21
factors affecting, 21 Intraocular probes, 13, 18
Intraocular units for wireless prostheses, 169–170
Iridium, 161, 219, 244, 311, 349 Iridium oxide, 160, 219
electroplated, voltammogram of, 236 redox reaction mechanisms of, 236–237
Iris, 2, 3–4, 272
Japanese Consortium for an Artificial Retina, 31
Joule heating, 287
Kernel weight, 157
Language processing, 52 Large-scale integration, 151–167 Lateral geniculate nucleus, 39 LCD displays, 270
infrared, 255
Learning, computer-aided, 111 Learning effects, 62–63, 81
visual, 48
Learning processes, 49–50, 116 LED illumination system, 272–273 Lens, 5
artificial, 5
Light, localization of, 100–101 Light-evoked potential, 194–197 Light perception, directional, 97 Light power, 272
Light responses, duplication of, 347–351 Light sensitivity, 92, 93
Limbus, 12, 22, 24, 36
Local field potential, 357–358 Local field potential recording, 359 Localization of light, testing
of, 100–101
Low vision enhancement system, 72–73
Macula lutea, 308 Macular chip design, 258 Macular degeneration
age-related, 14–15, 18, 71, 111, 120, 129, 170, 209, 255–256, 280, 334, 347
disciform, 15 dry, 14, 15 incidence of, 14 neovascular, 14 remapping in, 48 treatments for, 15 wet, 14
Magnetic resonance imaging, 48, 50–51, 53, 54, 59, 60
Magnetoencephalography, 56 Materials, 1, 244, 335
adhesive, 245 biocompatibility of, 119 electrode, 218–219
charge capacity of, 117 polyimide, 162
Index 387
Materials science, 209–224 Mechanical damage, 2
Membrane potential, changes in, 374 Metabolic heat, 287
Microarray implants, 169–186 Microchip arrays, 162–166 Microchips, distributed, 162–166 Microelectrode arrays
high-density, 244 implantation of, 210, 227 planar, 236
Microelectrodes, 111–112, 114, 116, 183 fine wire, 364
intracortical, formation of, 310 iridium oxide, 212
metal, 213
production techniques for, 245 stimulating, 307–321
tissue responses to, 311–321 Microelectronic devices, 17
implantation of in eye, 21–23 Microfabrication, 369
thin-film and MEMS, 239 Micromachining, 245 Micromanipulator, robotic, 373 Microneuromas, 17 Microphotodiode arrays, 23–25
Microstimulating arrays, implantation of, 311 Microstimulation with intracortical electrodes,
307–321 Mobility trainers, 106 Modeling
component, 289–294 electromagnetic effects, 279–303 extracellular stimulation, 259–261 numerical methods for, 301 thermal effects, 279–303
Models
2-D vs. 3-D, 300 computational, 379 layered retina, 295 multi-resolution, 300 sparse-matrix, 301
Molding, nanopowder, 243 Molyneaux’s Question, 57–62 Monophasic waveforms, 214 Motion, detection of, 97, 101 Motion processing, 53, 59
differences in, 51–52 Müller cells, 8, 17, 41
Multi-electrode arrays, 189, 336 Multi-electrode stimulation, simultaneous,
340–341, 343
Multifocal electroretinograms, 363–364
388 Index
Multiplexed signal, 184
Multiplexing techniques, 172, 185
Mylar films, 267
Nanoparticles
molding of, 243, 244, 245, 246–253 platinum, 246
Nernstian equation, 237 Nerve cells, 111
electrical stimulation of, 17–19 Neural cells, 269
retinal, 260
electrical stimulation of, 257 Neural circuits, 256, 307
Neural damage, threshold of, 330 Neural encoder, 198
Neural injury, 319 stimulation-induced, 212
Neural interface, 188
Neural network of the retina, 365 Neural prostheses, 227
implantable microelectronic devices for, 243 intracortical microstimulation, 309–311
Neural recording, 244 Neurological stimulation, 243–253
Neurons, 17, 34, 49, 54, 62, 184, 258, 309 cortical, 311
electrical activity of, 39 first-order, 373
injury to, 312–316
lateral geniculate nucleus, 39 populations of, 373, 375 post-synaptic, 365
relative order of, 374 retinal, 8, 355, 370
spike timing between, 348 secondary, rewiring of, 72 third-order, 376
visual, 274 Neuroprotection
electrically induced, 32, 39–43 transcorneal electrical stimulation
induced, 41 Neurostimulator, 121
N -methyl-D-aspartic acid, 375–377
Obstacles, detection of, 106
Occipital responses, functional role of, 55 Ocular dimensions, average, 8–9
Ocular implants, 1 Ohm’s Law, 287, 298
Optical coherence tomography (OCT), 10 Optical information, acquisition of, 91
Optical projection, direct, 258 Optic nerve, 6, 21, 34, 41, 95, 355
axons of, 188, 308
electrical stimulation of, 189–206 testing of, 95
transection of, 40, 41
Optic nerve sheath, 191, 193, 194, 195–196 Optoelectronic implants, design of, 273–274 Orbital cavity, 3
components of, 2 Orientation, testing of, 107 Outer nuclear layer, 6, 16
Outer nuclear layer cells, irregular, 329
Paired-flash electroretinograms, 362–363 Parietal cortex, 54
Partial inductance method, 279, 281–283 simulation of, 282–286
Parylene, 244, 310
Pattern electroretinograms, 363 Patterns
recognition of, 59
temporal, retinal light-response, 347–353 Perceived objects, size of, 124
Perception, flickering/non-flickering, 18, 99, 133, 136, 308
Percepts, 308, 356
Perceptual threshold, definition of, 122 Perfluordecaline, 119
Perforated membranes, 268–269 Perimetry, 92
Peripheral vision, loss of, 21
Pharmacological dissection, 365–366, 374–378 pH changes
monitoring of, 229, 236 stimulus induced, 227–240
typical, 235
pH effects, minimization of, 240 pH electrodes, 229
calibration curves for, 237–238 iridium oxide, 236
micro, potential response of, 238 microarray, 230
thin-film construction of, 237 miniaturization of, 239 solid-state, advantages of, 239
pH measurements, 230–231
Phosphenes, 18, 33, 36, 40, 72, 84, 187, 257, 308, 319
Phosphene vision, simulated, 76 Photic stimulation, 195, 360 Photodynamic therapy, 15 Photolithography, 269–270, 369 Photoreceptor cells, 151, 161, 209
Photoreceptor damage, 210 Photoreceptor nuclei, 17 Photoreceptor response, 362
Photoreceptors, 6, 111, 114, 188, 274, 329, 365, 372, 377
degenerated, 33–34 Photosensitivity, variable, 155–156 Photosensors, 151
pH profiles, 2-D distributions of, 238–239 Physiology of the eye, 2–9
Pigment coding, 119
Pitch, changes in, identifying, 51 Pixel density, 257–258
Pixelized conditions, 74, 75, 81, 83, 85, 88 Pixel number, 211
Pixel spacing, 265–266 Plasticity
cross-modal, 52, 54–57, 61, 64 in deaf individuals, 55–57
increase of across the visual hierarchy, 49, 62 neural mechanisms underlying, 50
sensory, 47–50
Plasticity and age of deprivation, 62 Platinum, 159–160, 161, 162, 212, 213, 215,
217, 219, 222, 230, 244–245, 248, 250, 252, 262, 264–265, 273–274, 325
nanoparticles of, 246 Platinum black, 245 Platinum gray, 222–223 PMMA, 1, 5
Pocket processor, 112, 114 Poly-dimethylsiloxane, 244, 246 Polyimide, 244, 369 Polymethyl metacrylate, 1, 5 Polyurethane, 327
Power consumption, 135, 172, 204, 274 Power conversion, 175, 176–177
efficiency of, 140, 177–178 Power delivery, wireless, 138
Power deposition in tissue, 283, 285–287 Power dissipation, 204, 263, 291–294 Power requirements, 137–138
Power supplies, 174, 274
Power transfer efficiency, 140–141 Power transmission, 269–275, 279
wireless, 138–143, 169
Power used by retinal prostheses, 131–132 Practice effect, 81
Preclinical studies, 119
Pressure effect on the retina, 20–21 Projection system, 269–273 Prostheses
dual-unit, approach to, 280 epiretinal, 32, 210
Index 389
history of, 1–2 retinal, 347
all-intraocular, 21–23 diagram of, 22 design of, 178–184 development of, 357
dual-unit, 279–303 flexibility of, 131–132
high-resolution, 129–147, 255–275 implantation of, 162–167 intraocular, 1–25
early model of, 228 materials for, 1
power used by, 131–132 size constraints of, 213 size of, 131–132
subretinal, 32 visual
design of, 197–203 electronic, 209 epiretinal, 343 ICMS, 307–321
pH changes in, 227–240 resolution of, 334
Prosthesis wearers, training methods for, 86 Prosthetic devices
interference with cross-modal processing by, 55
retinal, 162–167, 209–224, 347 all-intraocular, 21–23 dual-unit, 279–303
high-resolution, 129–147, 255–275 intraocular, 1–25
materials for, 1
power used by, 131–132 Prosthetic stimulation, 347–353 Prosthetic vision, modeling of, 71–89 Proximity, cell-electrode, 258, 259–266 Pseudocapacitive voltage step, 262
Psychometric threshold, definition of, 105 Psychophysical testing, 96, 97–105
elements of, 98
technical setup for, 98–100
Pulse amplitudes, 190–191, 193–194, 202 Pulse configuration, 214
Pulse duration, 190–191, 193–194, 202 Pulse frequency, 202
Pulse frequency modulation, 151
Pulse frequency modulation image sensor, 154 Pulse frequency modulation photosensor,
152–162
modification of, 154–156 Pulses
biphasic, 134, 262, 273, 292, 308, 327, 349
